{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:38:37Z","timestamp":1787503117063,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanchang Science and Technology Proiect","award":["YLW-2023-S019"],"award-info":[{"award-number":["YLW-2023-S019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00724-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:54:28Z","timestamp":1768038868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The prognosis characteristics of HIV\/HBV co-infection after antiviral therapy: a comprehensive review"],"prefix":"10.1186","volume":"21","author":[{"given":"Ai","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Waleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"ShuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"4","key":"724_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/QAI.0000000000000992","volume":"72","author":"HN Kim","year":"2016","unstructured":"Kim HN, Nance R, Van Rompaey S, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016;72(4):437\u201343.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"724_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09540121.2019.1625316","volume":"32","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. AIDS Care. 2020;32(3):294\u2013315. https:\/\/doi.org\/10.1080\/09540121.2019.1625316.","journal-title":"AIDS Care"},{"issue":"9","key":"724_CR3","doi-asserted-by":"publisher","first-page":"e44611","DOI":"10.1371\/journal.pone.0044611","volume":"7","author":"C Rossi","year":"2012","unstructured":"Rossi C, Shrier I, Marshall L, et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS ONE. 2012;7(9):e44611. https:\/\/doi.org\/10.1371\/journal.pone.0044611.","journal-title":"PLoS ONE"},{"key":"724_CR4","doi-asserted-by":"publisher","first-page":"1211980","DOI":"10.3389\/fimmu.2023.1211980","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Chen S, Liu H, et al. Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients. Front Immunol. 2023;14:1211980. https:\/\/doi.org\/10.3389\/fimmu.2023.1211980.","journal-title":"Front Immunol"},{"issue":"14","key":"724_CR5","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1017\/S0950268817001979","volume":"145","author":"SHI Hofstraat","year":"2017","unstructured":"Hofstraat SHI, Falla AM, Duffell EF, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors, and pregnant women in the EU\/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873\u201385. https:\/\/doi.org\/10.1017\/S0950268817001979.","journal-title":"Epidemiol Infect"},{"issue":"10003","key":"724_CR6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X.","journal-title":"Lancet"},{"issue":"2","key":"724_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3760\/cma.j.cn112338-20200317-00158","volume":"42","author":"Y Cao","year":"2021","unstructured":"Cao Y, Zhou M, Zhai X, et al. Systematic review and meta-analysis of hepatitis B virus coinfection in the HIV-positive population in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(2):327\u201334. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20200317-00158.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"27","key":"724_CR8","first-page":"369","volume":"92","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Hepatitis B vaccines: WHO position paper \u2013 July 2017. Wkly Epidemiol Rec. 2017;92(27):369\u201392. https:\/\/www.who.int\/publications\/i\/item\/WER9227.","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"724_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-1293.2008.00646.x","volume":"10","author":"C Bellini","year":"2009","unstructured":"Bellini C, Keiser O, Chave JP, et al. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV cohort study. HIV Med. 2009;10(1):12\u20138. https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00646.x. Epub 2008 Sep 12. PMID: 18795964.","journal-title":"HIV Med"},{"issue":"5","key":"724_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jgh.15315","volume":"36","author":"YJ Wong","year":"2021","unstructured":"Wong YJ, Thurairajah PH, Kumar R, et al. Efficacy and safety of sofosbuvir\/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort. J Gastroenterol Hepatol. 2021;36(5):1300\u20138. https:\/\/doi.org\/10.1111\/jgh.15315.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Pt 5","key":"724_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1099\/jmm.0.46350-0","volume":"55","author":"AA Adjei","year":"2006","unstructured":"Adjei AA, Armah HB, Gbagbo F, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol. 2006;55(Pt 5):593\u20137. https:\/\/doi.org\/10.1099\/jmm.0.46350-0.","journal-title":"J Med Microbiol"},{"issue":"3","key":"724_CR12","doi-asserted-by":"publisher","first-page":"ofw140","DOI":"10.1093\/ofid\/ofw140","volume":"3","author":"M Anderson","year":"2016","unstructured":"Anderson M, Gaseitsiwe S, Moyo S, et al. Slow CD4\u2009+\u2009T-cell recovery in human immunodeficiency virus\/hepatitis B virus-coinfected patients initiating Truvada-based combination antiretroviral therapy in Botswana. Open Forum Infect Dis. 2016;3(3):ofw140. https:\/\/doi.org\/10.1093\/ofid\/ofw140.","journal-title":"Open Forum Infect Dis"},{"key":"724_CR13","unstructured":"World Health Organization. Global hepatitis report 2023 [Internet]. Geneva: World Health Organization. 2023 [cited 2025 Aug 10]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240069923"},{"issue":"6","key":"724_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.aids.0000163938.60702.04","volume":"19","author":"D Konopnicki","year":"2005","unstructured":"Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to HAART, and increased mortality in the EuroSIDA cohort. AIDS. 2005;19(6):593\u2013601. https:\/\/doi.org\/10.1097\/01.aids.0000163938.60702.04.","journal-title":"AIDS"},{"key":"724_CR15","doi-asserted-by":"publisher","first-page":"1381826","DOI":"10.3389\/fcimb.2025.1381826","volume":"15","author":"M Xia","year":"2025","unstructured":"Xia M, Zhang Y, Li J, et al. Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in individuals with HIV\/HBV coinfection after combined antiretroviral therapy. Front Cell Infect Microbiol. 2025;15:1381826. https:\/\/doi.org\/10.3389\/fcimb.2025.1381826.","journal-title":"Front Cell Infect Microbiol"},{"key":"724_CR16","doi-asserted-by":"publisher","first-page":"713981","DOI":"10.3389\/fmed.2021.713981","volume":"8","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Xu Y, Li X, et al. HIV\/HBV coinfection: impact on the development and progression of liver disease. Front Med. 2021;8:713981. https:\/\/doi.org\/10.3389\/fmed.2021.713981.","journal-title":"Front Med"},{"issue":"6","key":"724_CR17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3760\/cma.j.cn311365-20240118-00038","volume":"40","author":"LH Li","year":"2024","unstructured":"Li LH. Chinese expert consensus on the diagnosis and treatment of HIV co-infection with HBV and HCV. Chin J Infect Dis. 2024;40(6):1107\u201313. https:\/\/doi.org\/10.3760\/cma.j.cn311365-20240118-00038.","journal-title":"Chin J Infect Dis"},{"key":"724_CR18","doi-asserted-by":"publisher","unstructured":"Audsley J, Avihingsanon A, Li X, et al. Kinetics and predictors of HBsAg loss after commencing HBV-active ART in HIV\/HBV co-infection. Clin Infect Dis. 2025;ciaf281. https:\/\/doi.org\/10.1093\/cid\/ciaf281.","DOI":"10.1093\/cid\/ciaf281"},{"issue":"2","key":"724_CR19","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-19","volume":"33","author":"MH Nguyen","year":"2020","unstructured":"Nguyen MH, Wong G, Gane E, et al. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):e00084\u201319. https:\/\/doi.org\/10.1128\/CMR.00084-19.","journal-title":"Clin Microbiol Rev"},{"key":"724_CR20","doi-asserted-by":"publisher","unstructured":"Maylin S, Boyd A, Lavocat F et al. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients. AIDS. 2012;26(8):939\u2009\u2013\u200949. https:\/\/doi.org\/10.1097\/QAD.0b013e328352224d. PMID: 22333748.","DOI":"10.1097\/QAD.0b013e328352224d"},{"issue":"6","key":"724_CR21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/cid\/ciad856","volume":"78","author":"MJ Vinikoor","year":"2024","unstructured":"Vinikoor MJ, Hamusonde K, Muula G, et al. Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV\/HIV coinfection in Zambia. Clin Infect Dis. 2024;78(6):1583\u201390. https:\/\/doi.org\/10.1093\/cid\/ciad856.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"724_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/hiv.13766","volume":"26","author":"C B\u00e9guelin","year":"2025","unstructured":"B\u00e9guelin C, Surial B, Hofmann E, et al. Frequent hepatitis B surface antigen (HBsAg) clearance during Tenofovir therapy in persons with HIV\/hepatitis B virus coinfection. HIV Med. 2025;26(5):813\u201319. https:\/\/doi.org\/10.1111\/hiv.13766.","journal-title":"HIV Med"},{"issue":"11\u201312","key":"724_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/09564624251352345","volume":"36","author":"F Tabak","year":"2025","unstructured":"Tabak F, Y\u0131ld\u0131z Sevgi D, Zerdali E, et al. Efficacy of Tenofovir alafenamide- or Tenofovir disoproxil fumarate-containing regimens in adults with treatment-na\u00efve HIV-hepatitis B co-infection. Int J STD AIDS. 2025;36(11\u201312):857\u201362. Epub 2025 Jun 18. PMID: 40532233.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"724_CR24","first-page":"105","volume":"31","author":"M Fern\u00e1ndez-Prada","year":"2018","unstructured":"Fern\u00e1ndez-Prada M, Rodr\u00edguez-Fonseca OD, et al. Use of hepatitis B AS04C adjuvanted vaccine in HIV patients. Rev Esp Quimioter. 2018;31(2):105\u20139. https:\/\/www.sequipedro.es\/index.php\/seq\/article\/view\/1515.","journal-title":"Rev Esp Quimioter"},{"key":"724_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12879-020-4856-3","volume":"20","author":"TG Mapongaa","year":"2020","unstructured":"Mapongaa TG, McNaughton AL, van Schalkwyk M, et al. Treatment advantage in HBV\/HIV coinfection compared to HBV monoinfection in a South African cohort. BMC Infect Dis. 2020;20:121. https:\/\/doi.org\/10.1186\/s12879-020-4856-3.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"724_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s10654-014-9916-8","volume":"29","author":"G Corrao","year":"2014","unstructured":"Corrao G, Carle F, Lepore AR, et al. Interaction between alcohol consumption and positivity for antibodies to the hepatitis C virus on the risk of liver cirrhosis: a case-control study. Eur J Epidemiol. 2014;29(5):634\u20139. https:\/\/doi.org\/10.1007\/s10654-014-9916-8.","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"724_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2893.2012.01606.x","volume":"19","author":"L Kosi","year":"2012","unstructured":"Kosi L, Reiberger T, Payer BA, et al. Five-year on-treatment efficacy of lamivudine, tenofovir, and tenofovir\u2009+\u2009emtricitabine-based HAART in HBV-HIV-coinfected patients. J Viral Hepat. 2012;19(11):801\u201310. https:\/\/doi.org\/10.1111\/j.1365-2893.2012.01606.x.","journal-title":"J Viral Hepat"},{"key":"724_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12879-018-3425-0","volume":"18","author":"P Jayne","year":"2018","unstructured":"Jayne P, Ellis N, Kalata N, et al. Ischemic stroke as a complication of Cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report. BMC Infect Dis. 2018;18:520. https:\/\/doi.org\/10.1186\/s12879-018-3425-0.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"724_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/HEP.0000000000000087","volume":"80","author":"M Xu","year":"2024","unstructured":"Xu M, Warner C, Duan X, et al. HIV coinfection exacerbates HBV-induced liver fibrogenesis through an HIF-1\u03b1- and TGF-\u03b21-dependent pathway. Hepatology. 2024;80(6):868\u201381. https:\/\/doi.org\/10.1097\/HEP.0000000000000087.","journal-title":"Hepatology"},{"key":"724_CR30","doi-asserted-by":"publisher","first-page":"04029","DOI":"10.7189\/jogh.14.04029","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang H, Li X, et al. The trend of AIDS in china: a prediction and comparative analysis with G20 countries. J Glob Health. 2024;14:04029. https:\/\/doi.org\/10.7189\/jogh.14.04029.","journal-title":"J Glob Health"},{"issue":"2","key":"724_CR31","doi-asserted-by":"publisher","first-page":"e88654","DOI":"10.1371\/journal.pone.0088654","volume":"9","author":"J van Griensven","year":"2014","unstructured":"van Griensven J, Phirum L, Choun K, et al. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery, and antiretroviral toxicity in Cambodia. PLoS ONE. 2014;9(2):e88654. https:\/\/doi.org\/10.1371\/journal.pone.0088654.","journal-title":"PLoS ONE"},{"key":"724_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11904-019-00456-6","volume":"16","author":"KW Chew","year":"2019","unstructured":"Chew KW, Bhattacharya D, Chang K, et al. Epidemiology of HIV and hepatitis B and C virus coinfections: global and regional perspectives. Curr HIV\/AIDS Rep. 2019;16:220\u201333. https:\/\/doi.org\/10.1007\/s11904-019-00456-6.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"724_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clinre.2016.11.008","volume":"41","author":"ZQ Li","year":"2017","unstructured":"Li ZQ, Hu CL, Yu P, et al. The development of hepatocarcinoma after long-term antiviral treatment of Chinese patients with chronic hepatitis B virus infection: incidence, long-term outcomes, and predictive factors. Clin Res Hepatol Gastroenterol. 2017;41(3):311\u201318. https:\/\/doi.org\/10.1016\/j.clinre.2016.11.008.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"724_CR34","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1111\/jvh.12182","volume":"21","author":"S Naggie","year":"2014","unstructured":"Naggie S, Patel K, McHutchison J, et al. Clinical features and outcomes of HIV\/HCV coinfected patients: a cohort study. J Viral Hepat. 2014;21(3):e34\u201340. https:\/\/doi.org\/10.1111\/jvh.12182.","journal-title":"J Viral Hepat"},{"issue":"2","key":"724_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.35769\/cjh.2025.02.008","volume":"29","author":"M Chen","year":"2025","unstructured":"Chen M, Liu C, Tang X, et al. Long-term impact of hepatitis B virus coinfection on the occurrence of abnormal liver enzymes in HIV-infected individuals in Guangzhou. Chin J Hepatol. 2025;29(2):178\u201384. https:\/\/doi.org\/10.35769\/cjh.2025.02.008.","journal-title":"Chin J Hepatol"},{"key":"724_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1186\/s12879-020-05598-8","volume":"20","author":"SA Balogun","year":"2020","unstructured":"Balogun SA, Balogun ST, Phil RO, et al. Prevalence of HBV, HCV, syphilis, and tuberculosis among people living with HIV: a systematic review. BMC Infect Dis. 2020;20:891. https:\/\/doi.org\/10.1186\/s12879-020-05598-8.","journal-title":"BMC Infect Dis"},{"key":"724_CR37","doi-asserted-by":"publisher","first-page":"100868","DOI":"10.1016\/j.jhepr.2023.100868","volume":"5","author":"AJ Stockdale","year":"2023","unstructured":"Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. JHEP Rep. 2023;5:100868. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100868.","journal-title":"JHEP Rep"},{"issue":"15","key":"724_CR38","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001584","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh KP, Crane M, Audsley J, et al. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31(15):2035\u201352. https:\/\/doi.org\/10.1097\/QAD.0000000000001584.","journal-title":"AIDS"},{"issue":"1","key":"724_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12879-024-09284-2","volume":"24","author":"J Tang","year":"2024","unstructured":"Tang J, Weng R, Fang T, et al. Clinical outcomes of liver transplantation in human immunodeficiency virus\/hepatitis B virus coinfected patients in China. BMC Infect Dis. 2024;24(1):383. https:\/\/doi.org\/10.1186\/s12879-024-09284-2. PMID: 38589801; PMCID: PMC11003048.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"724_CR40","doi-asserted-by":"publisher","first-page":"e0215369","DOI":"10.1371\/journal.pone.0215369","volume":"14","author":"R Boateng","year":"2019","unstructured":"Boateng R, Mutocheluh M, Dompreh A, et al. Sero-prevalence of hepatitis B and C viral co-infections among HIV-1 infected ART-na\u00efve individuals in Kumasi, Ghana. PLoS ONE. 2019;14(4):e0215369. https:\/\/doi.org\/10.1371\/journal.pone.0215369.","journal-title":"PLoS ONE"},{"issue":"5","key":"724_CR41","doi-asserted-by":"publisher","first-page":"e0300149","DOI":"10.1371\/journal.pone.0300149","volume":"19","author":"A Gedefie","year":"2024","unstructured":"Gedefie A, Debash H, Asmamaw S, et al. Epidemiology of an overlapping and parallel infection of sexually transmitted infections among pregnant women in North-east ethiopia: its implication for prevention of mother to child transmission. PLoS ONE. 2024;19(5):e0300149. https:\/\/doi.org\/10.1371\/journal.pone.0300149. PMID: 38768132; PMCID: PMC11104588.","journal-title":"PLoS ONE"},{"key":"724_CR42","doi-asserted-by":"publisher","unstructured":"Peters L, Mocroft A, Grint D et al. Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Antivir Ther. 2018;23(5):405\u2013413. https:\/\/doi.org\/10.3851\/IMP3218. PMID: 29303483.","DOI":"10.3851\/IMP3218"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00724-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T02:37:48Z","timestamp":1770259068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00724-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00724-5","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}